Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) shares rose 50% on Wednesday . The stock traded as high as C$0.11 and last traded at C$0.11. Approximately 1,942,446 shares traded hands during mid-day trading, an increase of 1,795% from the average daily volume of 102,479 shares. The stock had previously closed at C$0.07.
Voyageur Pharmaceuticals Stock Performance
The firm’s 50 day moving average price is C$0.07 and its 200-day moving average price is C$0.06. The firm has a market cap of C$13.95 million, a price-to-earnings ratio of -10.00 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Recommended Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- Pros And Cons Of Monthly Dividend Stocks
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- What Is WallStreetBets and What Stocks Are They Targeting?
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- Dividend Capture Strategy: What You Need to Know
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
